A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight (TRIUMPH-2)
Type 2 Diabetes, Obesity, Overweight

About this trial
This is an interventional treatment trial for Type 2 Diabetes
Eligibility Criteria
Inclusion Criteria: Have a body mass index (BMI) greater than or equal to 27.0 kilogram/square meter (kg/m ²) Have Type 2 Diabetes (T2D) Are on stable treatment for T2D for at least 90 days Have a history of at least one unsuccessful dietary effort to lose body weight. GSA2 Inclusion Criteria Previously diagnosed with OSA Have AHI ≥15 on polysomnography at screening (definition of moderate-to-severe OSA) For participants not on positive airway pressure (PAP) therapy: unable or unwilling to use PAP therapy and have not used PAP for at least 4 weeks prior to screening. If on PAP therapy, have been on PAP therapy for at least 3 consecutive months prior to screening, and willing to temporarily stop using PAP therapy for approximately 7 days prior to each of the sleep study (PSG) visits. Exclusion Criteria: Have a self-reported or documented change in body weight >5 kg (11 pounds) within 90 days. Have taken weight loss drugs, including over-the-counter medications, within 90 days prior to screening. Have a prior or planned surgical treatment for obesity. Have Type 1 diabetes Have a family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN-2) Have had pancreatitis GSA2 Exclusion Criteria Use stimulants (for example, modafinil, armodafinil, solriamfetol, pitolisant, amphetamine) less than 3 months prior to screening. Use hypnotics, mirtazapine, opioids, trazodone, and zonisamide less than 3 months prior to screening. Use a dental appliance or other device to treat OSA other than PAP therapy.
Sites / Locations
- National Research Institute - WilshireRecruiting
 - Valley Clinical Trials, Inc.Recruiting
 - Diablo Clinical Research, Inc.Recruiting
 - Chase Medical Research, LLCRecruiting
 - Teradan Clinical Trials, LLCRecruiting
 - Renstar Medical ResearchRecruiting
 - Palm Beach Research CenterRecruiting
 - NeuroTrials Research IncRecruiting
 - East-West Medical Research InstituteRecruiting
 - Brengle Family MedicineRecruiting
 - MedVadis Research CorporationRecruiting
 - StudyMetrix ResearchRecruiting
 - Las Vegas Medical ResearchRecruiting
 - Carteret Medical GroupRecruiting
 - Lillestol ResearchRecruiting
 - CTI-CRCRecruiting
 - Office 18Recruiting
 - Tribe Clinical Research, LLCRecruiting
 - Trial Management AssociatesRecruiting
 - Tribe Clinical Research - SpartanburgRecruiting
 - FutureSearch Trials of NeurologyRecruiting
 - Dallas Diabetes Research CenterRecruiting
 - Advanced Research InstituteRecruiting
 - Centro Médico Viamonte
 - Consultorio de Investigación Clínica EMO SRL
 - Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
 - Centro de Salud e Investigaciones Médicas
 - The AIM Centre / Hunter Diabetes CentreRecruiting
 - Woolcock Institute of Medical ResearchRecruiting
 - Royal Brisbane and Women's HospitalRecruiting
 - Core Research GroupRecruiting
 - Nightingale ResearchRecruiting
 - Southern Adelaide Diabetes & Endocrine ServicesRecruiting
 - Flinders UniversityRecruiting
 - Box Hill HospitalRecruiting
 - Austin Health - Repatriation HospitalRecruiting
 - GenesisCareRecruiting
 - The Second Affiliated Hospital of Zhengzhou University
 - Baotou Central Hospital
 - Nanjing First Hospital
 - The Second Affiliated Hospital of Nanjing Medical University
 - The First Hospital of Jilin University
 - The First Affiliated Hospital of Xi'an Medical University
 - Pudong New Area People's Hospital Shanghai
 - West China Hospital of Sichuan University
 - Ningbo First Hospital
 - V.S. General Hospital
 - Avron Hospitals
 - Zydus Hospitals & Healthcare Research Pvt.Ltd.
 - Life Care Hospital and Research CentreRecruiting
 - Sushruta Multispeciality Hospital & Research Centre
 - CHL Hospital IndoreRecruiting
 - Sawai Man Singh Medical College Hospital (SMS Hospital)
 - Madras Diabetes Research Foundation
 - Christian Medical College Vellore
 - Care Hospitals Hyderabad- Banjara HillsRecruiting
 - Kumudini Devi Diabetes Research Center
 - Institute of Post Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital
 - Korea University Ansan HospitalRecruiting
 - Hanyang University Guri HospitalRecruiting
 - Yeungnam Univeristy Medical CenterRecruiting
 - Seoul National University HospitalRecruiting
 - Severance Hospital, Yonsei University Health System
 - Ulsan University Hospital
 - Centro de Investigacion en Artritis y Osteoporosis SC
 - RM Pharma Specialists
 - Centro Especializado En Diabetes, Obesidad Y Prevencion De Enfermedades Cardiovasculares
 - Diseno y Planeacion en Investigacion Medica
 - Private Practice - Dr. Arechavaleta Granell Maria del Rosario
 - Unidad de Investigación Clínica y Atención Médica HEPA
 - Cardiolink Clin Trials
 - Investigacion En Salud Y Metabolismo S.C / Nutricion Clinica / Unidad de Base de Datos
 - FAICIC S. de R.L. de C.V.
 - Arké SMO S.A de C.V
 - DiabdanaRecruiting
 - Geea Medical Easy DietRecruiting
 - Centrul Medical NutriLifeRecruiting
 - Gama DiamedRecruiting
 - Centrul Medical MediabRecruiting
 - CMI Dr.Pletea Noemi SRLRecruiting
 - Centro Periférico de Especialidades Bola AzulRecruiting
 - Hospital Universitario Virgen de la VictoriaRecruiting
 - Complejo Asistencial Universitario de León - Hospital de LeónRecruiting
 - Hospital Universitario Ramón y CajalRecruiting
 - Vithas Hospital SevillaRecruiting
 - Hospital Universitario Virgen Del RocioRecruiting
 - Chang Gung Memorial Hospital at Kaohsiung
 - Chung Shan Medical University Hospital
 - Taipei Veterans General Hospital
 
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Placebo Comparator
Retatrutide Dose 1
Retatrutide Dose 2
Retatrutide Dose 3
Placebo
Participants will receive retatrutide subcutaneously (SC).
Participants will receive retatrutide SC.
Participants will receive retatrutide SC.
Participants will receive placebo.